SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-025520
Filing Date
2024-03-25
Accepted
2024-03-25 16:01:51
Documents
1
Period of Report
2023-11-25

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3066
  Complete submission text file 0001213900-24-025520.txt   4545
Mailing Address SUITE 105 - 5348 VEGAS DR. LAS VEGAS NV 89108
Business Address SUITE 105 - 5348 VEGAS DR. LAS VEGAS NV 89108 702-442-1166
Raphael Pharmaceutical Inc. (Issuer) CIK: 0001415397 (see all company filings)

IRS No.: 260204284 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)

Mailing Address 4 LUI PASTER TEL AVIV-JAFFA L3 6803605
Business Address
Eliya Yehuda (Reporting) CIK: 0001904163 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-53002 | Film No.: 24779146